| # | 📅 Date / Time (stacked) |
📄 Cleaned Text (headlines) | 📖 Translation | ⚡ Action | 💡 Jay Bharat Idea & Notes |
|---|---|---|---|---|---|
| 1 | Smartworks: Expands Managed Office Deal Across Multiple Cities With Forbes 2000 Global Customer; Seats Top 5,000. Indus Towers: IIFL Says Dividend Or Share Buyback Could Be Announced Alongside Q4 Results — CNBC-TV18 |
📌 Shareholder reward – positive cash return.
|
BUY |
💡 🏢 Managed office expansion – commercial real estate play.
|
|
| 2 | FII Investors Sell India Shares Worth Rs 8,167.17 Crore, While DII Investors Buy Net Rs 8,088.70 Crore Today |
📌 Positive brokerage stance – expected upside.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 3 | TRUMP: IF A CERTAIN PRESIDENT HAD DONE HIS JOB, NORTH KOREA WOULDN'T HAVE NUCLEAR WEAPONS NOW. TRUMP: SOUTH KOREA, AUSTRALIA & JAPAN DIDN'T HELP US; WE HAVE 50,000 TROOPS IN JAPAN & 45,000 IN... SAUDI ARABIA, QATAR & UAE HAVE BEEN HELPFUL TO THE US |
📌 Corporate action / market update / brokerage research.
|
NoAction |
💡 📌 Monitor further news / earnings flow.
|
|
| 4 | Blue Cloud Softech: Company Buyout Of Global ImP X Inc To Build An AI-Driven Energy And Digital Infrastructure Platform, Valuing The Target At Rs 372.8. JUST DIAL: CO TO CONSIDER Q4 RESULT ON APRIL 13 |
📌 Positive brokerage stance – expected upside.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 5 | Fii Sell Net Rupees 8,692.11 Cr Of India Shares Today || Dii Buy Net Rupees 7,979.50 Cr |
📌 Foreign outflows, domestic buying partially offsets – volatility likely.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 6 | Zydus Life: Receives Final USFDA Approval For Dapagliflozin 5 Mg And 10 Mg Tablets, After Annual Sales Of $10.2 Billion. Due to abnormal volatility in GODFRYPHLP, RVNL, GMRAIRPORT, IRFC, BANKNIFTY, FINNIFTY & IRED... POSITIONAL CALL: OUR BUY CALL OF CARTRADE TECH ON 07.04.2026 AT 1822 IS NOW 1882. BOOK PROFIT. |
📌 USFDA approval for Dapagliflozin (diabetes drug) – large market opportunity.
|
BUY |
💡 💊 Dapagliflozin approval – $10B+ market, generic opportunity.
|
|
| 7 | Lupin: Co Gets US Approval For Dapagliflozin Plus Metformin Hydrochloride Tablets. Qatar Begins Work To Resume Production At LNG Export Hub. NHPC: CO Approved Investment For 1,720 MW Kamala Hydroelectric Project Worth Rs 260.7 Billion |
📌 USFDA approval for Dapagliflozin (diabetes drug) – large market opportunity.
|
NoAction |
💡 💊 Dapagliflozin approval – $10B+ market, generic opportunity.
|
|
| 8 | HDFC Asset Management Company: HSBC on HDFC Asset Management maintains Hold with Target Price ₹2,580 as weak equity markets create dual pressure on AMC earnings and growth, with life insurers most impacted. |
📌 Brokerage rating update – direction depends on rating.
|
HOLD |
💡 📌 Monitor further news / earnings flow.
|
|
| 9 | Anand Rathi Wealth: Co Approves Final Dividend Of Rs. 7 Per Share. Dilip Buildcon: Company Declared As L1 Bidder For Rs 268 Crore EPC Project For Ged Barrage On Sabarmati River. World Bank: India's FY27 Current Account Deficit Seen Rising To 1.8% Of GDP As Energy Import Costs Climb |
📌 Shareholder reward – positive cash return.
|
BUY |
💡 💰 ₹7 dividend – wealth management co, steady yield.
|
|
| 10 | POSITIONAL CALL: BUY TCS (NSE Symbol TCS) AT 2590 FOR TARGET Of 2850, STOP LOSS 2440. Cipla Ltd.: Rs. 18.49 Crores NSE Block Trade; for ~ 150,461 Shares, at Rs. 1228.80 |
📌 Derivative/equity long recommendation (speculative, high risk).
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 11 | TATA CONSULTANCY SERVICES: CO RECOMMENDED A FINAL DIVIDEND OF RS 31 PER EQUITY SHARE |
📌 Shareholder reward – positive cash return.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 12 | POSITIONAL CALL: BUY TEJAS NETWORKS (NSE Symbol TEJASNET) AT 458.5 FOR TARGET OF 600, STOP LOSS 380. RailTel: Secures ₹23.18 Crore Work Order From Goa Building Welfare Board To Build Exclusive Online Portal. |
📌 Derivative/equity long recommendation (speculative, high risk).
|
BUY |
💡 📡 Positional buy target 600 – defence/telecom equipment.
|
|
| 13 | POSITIONAL CALL: BUY INDIA GLYCOLS (NSE Symbol INDIAGLYCO) AT 932 FOR TARGET Of 1100, STOP LOSS 840. |
📌 Derivative/equity long recommendation (speculative, high risk).
|
BUY |
💡 🧪 Positional buy target 1100 – chemical specialty play.
|
|
| 14 | Titan Company: Morgan Stanley maintains Overweight with Target Price ₹5,102 (raised from ₹4,529), citing strong jewellery demand driving 4–8% revenue upgrades. NSE INDEX OPENS UP 0.44% IN PRE OPEN TRADE. India 10-Year Government Bond Yield Edges Up To 6.9610%. |
📌 Brokerage rating update – direction depends on rating.
|
BUY |
💡 💍 MS Overweight TP ₹5102 – jewellery demand strong.
|
|
| 15 | POSITIONAL CALL: BUY MAHINDRA & MAHINDRA (NSE Symbol M&M) AT 3245 FOR TARGET Of 3600, STOP LOSS 3015. |
📌 Derivative/equity long recommendation (speculative, high risk).
|
BUY |
💡 🚜 Positional buy target 3600 – auto/agri recovery.
|
|
| 16 | NSE Index Ends Up 1.16% Or +275.50 Points At 24,050.60. TATA Sons Listing Is Not Only Paperwork, Shapoorji Pallonji Mystery Says It Will Unlock Value. Symphony Limited: Receives VAT Order Cutting Tax Liability From ₹13.70 Cr To ₹12,563. |
📌 Market closed higher – broad positive sentiment.
|
NoAction |
💡 📌 Monitor further news / earnings flow.
|
|
| 17 | HCC: Investor Mukul Agrawal Boosts Stake From 1.68% To 1.91% In Q4. Power Mech Projects: Secures ₹296.44 Crore Order From Maha Mumbai Metro Operation Corporation. Reserve Limited Co. Announces Expansion Of Development Pipeline With INR 5,100+ Crore GDV. |
📌 Order win – revenue visibility positive.
|
NoAction |
💡 📈 Ace investor stake increase – sentiment positive.
|
|
| 18 | Tata Consultancy Services: Morgan Stanley maintains Overweight with Target Price ₹2,880 (cut from ₹3,540), citing in-line Q4 with slight geographic improvement, cautious FY27 outlook amid BFSI macro. HSBC maintains Hold with TP ₹2,755. Nomura maintains Buy with TP ₹2,930. |
📌 Brokerage rating update – direction depends on rating.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 19 | Tata Consultancy Services: HSBC Hold TP ₹2,755. Nomura Buy TP ₹2,930. Shilpa Medicare Ltd research report. |
📌 Positive brokerage stance – expected upside.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 20 | Tata Consultancy Services: Nomura Buy TP ₹2,930, strong deal wins. Delhivery: HSBC maintains Hold with Target Price ₹500 (raised), resilient share performance despite Middle East fuel inflation. |
📌 Brokerage rating update – direction depends on rating.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 21 | Tata Consultancy Services: JPMorgan maintains Overweight with TP ₹3,150, citing Q4 revenue beat, $12bn deal wins, 28% QoQ AI revenue growth. Kotak maintains Buy with TP ₹3,100. |
📌 Positive brokerage stance – expected upside.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 22 | Tata Consultancy Services: Kotak Buy TP ₹3,100. Shriram Finance: Morgan Stanley Overweight TP ₹1,325, AAA upgrade by ICRA post MUFG deal. |
📌 Positive brokerage stance – expected upside.
|
BUY |
💡 🏦 MS Overweight TP ₹1325 – AAA upgrade post MUFG deal.
|
|
| 23 | Tata Consultancy Services: InCred maintains Add with TP ₹3,052 (cut from ₹3,663). Shriram Finance Overweight. |
📌 Positive brokerage stance – expected upside.
|
BUY |
💡 🏦 MS Overweight TP ₹1325 – AAA upgrade post MUFG deal.
|
|
| 24 | Tata Consultancy Services: InCred Add TP ₹3,052. HDFC Securities maintains Add with TP ₹3,000. Jefferies Underperform TP ₹2,275. |
📌 Negative brokerage view – expected underperformance.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 25 | Tata Consultancy Services: Jefferies Underperform TP ₹2,275, margin miss, weak BFSI growth. CLSA maintains Outperform with TP ₹2,985. |
📌 Positive brokerage stance – expected upside.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
|
| 26 | Tata Consultancy Services: CLSA Outperform TP ₹2,985. Citi maintains Sell with TP ₹2,250, citing FY26 revenue decline of 2.4%. |
📌 Positive brokerage stance – expected upside.
|
BUY |
💡 📌 Monitor further news / earnings flow.
|
Logged out — showing 362 public records only. Login to see 382 private items.
No memories match this filter.
Jump to detailed list ↓ · 362 clickable cards
Comments (0)
No comments yet. Be the first to share your thoughts!